Striving for more reliable study results?
We focus on quality.

Associate member

The SCTO is an independent organisation and is based on a joint initiative of the Swiss National Science Foundation and the Swiss Academy of Medical Sciences.

As of 2017, the SCTO is a research infrastructure of national importance funded by the State Secretariat of Education, Research and Innovation and the Swiss National Science Foundation.

Regulatory Affairs


Dr Laure Vallotton, Centre Hospitalier Universitaire Vaudois, CTU Lausanne

SCTO Regulatory Affairs Platform
Hot off the press

Issue 3, March 2020

Click here to read an online version of RAW Issue 3.

Previous issues are available further below.

Keep up to date with Regulatory Affairs Watch

The email newsletter Regulatory Affairs Watch (RAW) aims to reach a wide, national audience: human research professionals, investigators, (potential) sponsors, regulators, members of ethics committees, professional organisations and patient associations.

RAW shares, at regular intervals, news of a scientific and regulatory nature, from Switzerland and abroad: articles, events and publications. Furthermore, each issue features a deep dive on a particular topic, accompanied by views and opinions of different organisations. The newsletter is published in English only. 

The newsletter was launched in April 2019 by the Regulatory Affairs Platform. Learn more about their activities in the fact sheet below.

Regulatory Affairs in brief

Regulatory affairs is a relatively new professional field. It emerged in the 1980s, when governments worldwide became compelled to better protect the public. Such protection includes ensuring that all medicines reaching society are optimally safe and effective. Regulatory professionals were developed to integrate sound regulatory practices into projects from start to finish, keeping them on the right legal track.

In the realm of clinical research, they assist their peers with clinical trials applications, from early days, ensuring that all the documents and processes accompanying a project are in place and are of the quality required. Regulatory affairs professionals assist in reviewing study plans (protocol) and preparing submissions to national authorities, amending as needed, placing the trial in a registry, and following it through with the final study reports. All documents must be reviewed, complete, scientifically accurate, in regulatory compliance, and presented so as to facilitate the review and approval process of the ethics committees and – if needed – of the competent authorities.

Would you like to know how the experts in the Regulatory Affairs Platform are channeling their efforts? For more information, consult the fact sheet below.